Gout drug colchicine doesn’t lessen COVID-19 severity or stave off risk of death

Colchicine, a cheap anti-inflammatory drug normally used to treat gout, doesn’t lessen COVID-19 severity or stave off the risk of death from the infection in hospital patients, finds a pooled analysis of the available evidence, published in the open access journal RMD Open.
Did you miss our previous article…
https://www.integurx.net/?p=188